Dermatology Series
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond
Dermatology Series
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond
Dermatology Series
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond
Dermatology Series
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond
Dermatology Series
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond
COVID-19 Webinar
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals and Lilly.
COVID-19 Webinar
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals and Lilly.
About this course
General
Skill level: All levels
Estimated time to complete activity: 1 Hour
Release date: April 07, 2020
Languages
English
Description
General immunosuppression can heighten the risk for infections, and this webinar will detail the risk for viral infections with immunosuppression and discuss strategies for immunosuppressive and immunomodulatory medication management during the COVID-19 pandemic.